Interventional Spine Devices Market by Procedure and Geography — Forecast and Analysis 2020–2024

The interventional spine devices market size has the potential to grow by USD 2.31 billion during 2020–2024, and the market’s growth momentum will accelerate during the forecast period.

This report provides a detailed analysis of the market by geographic landscape (North America, Europe, APAC, and ROW) and procedure (vertebroplasty, kyphoplasty radiofrequency ablation, and others). Also, the report analyzes the market’s competitive landscape. It offers information on several market vendors, including Abbott Laboratories, Alphatec Holdings Inc., Globus Medical Inc., Integra LifeSciences Corp., Johnson & Johnson, Medtronic Plc, Nuvasive Inc., RTI Surgical Holdings Inc., Stryker Corp., and Zimmer Biomet Holdings Inc.

Request for Free Sample Report

The increasing number of incidences of spine and bone disorders will significantly drive the demand for interventional spine devices. There has been a significant rise in the incidence of spinal disorders across the world. The most common spinal disorders include spondylolisthesis, degenerative disc disease, herniated discs, prolapsed intervertebral disc, and spinal stenosis. Disc herniation is a result of age-related degeneration of the annulus fibrosis or trauma, lifting injuries, or straining. Also, osteoporosis can lead to degenerative changes in the spinal discs, including intervertebral discs and spinal facets that require surgical intervention. Such factors will influence the growth of the interventional spine devices market, which will register a CAGR of about 10% during the forecast period.